Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

PMGC HOLDINGS INC. (ELAB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

PMGC HOLDINGS INC. (ELAB), most recent 12 months reported: revenue $2.58M, net loss $13.49M, free cash flow -$6.38M. Latest balance sheet on file: liquid cash $18.79M, total debt $9.08M, net cash $9.72M. From SEC filings. Others in Pharmaceutical Preparations: UPSTREAM BIO, INC. · Connect Biopharma Holdings Limited · BIO ESSENCE CORP. · Traws Pharma, Inc. · VISTAGEN THERAPEUTICS, INC. · Korro Bio, Inc. · NORTHWEST BIOTHERAPEUTICS INC · CYCLERION THERAPEUTICS, INC.

Stock screener

Watchlist